| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ceftriaxone | FAERS: 19 | US FAERS | |
| 2 | Ceftriaxone | FAERS: 14 | US FAERS | |
| 3 | Lamotrigine | FAERS: 12 | SIDER US FAERS | |
| 4 | Methylphenidate | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 5 | Lithium | FAERS: 6 | SIDER US FAERS | |
| 6 | Thyroxine | FAERS: 6 | US FAERS | |
| 7 | Azithromycin | FAERS: 5 | US FAERS | |
| 8 | Lithium Carbonate | FAERS: 5 | US FAERS | |
| 9 | Phenytoin | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Sertraline | FAERS: 5 | SIDER US FAERS | |
| 11 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 4 | US FAERS | |
| 12 | Bupropion | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 13 | Methamphetamine | FAERS: 4 | US FAERS | |
| 14 | Methylphenidate | FAERS: 4 | US FAERS | |
| 15 | Mirtazapine | FAERS: 4 | US FAERS | |
| 16 | Sertraline | FAERS: 4 | US FAERS | |
| 17 | Cefepime | FAERS: 3 | US FAERS | |
| 18 | Pregabalin | FAERS: 3 | US FAERS | |
| 19 | Risperidone | FAERS: 3 | SIDER US FAERS | |
| 20 | Acyclovir | FAERS: 2 | US FAERS | |
| 21 | Aripiprazole | FAERS: 2 | SIDER US FAERS | |
| 22 | Baclofen | FAERS: 2 | US FAERS | |
| 23 | Levetiracetam | FAERS: 2 | SIDER US FAERS | |
| 24 | Methamphetamine | FAERS: 2 | US FAERS | |
| 25 | Methotrexate | FAERS: 2 | US FAERS | |
| 26 | Metoclopramide | FAERS: 2 | US FAERS | |
| 27 | Permethrin | FAERS: 2 | US FAERS | |
| 28 | Anastrozole | FAERS: 1 | US FAERS | |
| 29 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 30 | Bortezomib | FAERS: 1 | US FAERS | |
| 31 | Carbamazepine | FAERS: 1 | SIDER US FAERS | |
| 32 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 33 | Citalopram | FAERS: 1 | US FAERS | |
| 34 | Citalopram | FAERS: 1 | US FAERS | |
| 35 | Clonazepam | FAERS: 1 | US FAERS | |
| 36 | Clozapine | FAERS: 1 | US FAERS | |
| 37 | Dexmedetomidine | FAERS: 1 | US FAERS | |
| 38 | Docetaxel | FAERS: 1 | US FAERS | |
| 39 | Dronabinol | FAERS: 1 | US FAERS | |
| 40 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 41 | Hydroxocobalamin | FAERS: 1 | US FAERS | |
| 42 | Loperamide | FAERS: 1 | US FAERS | |
| 43 | Lorazepam | FAERS: 1 | US FAERS | |
| 44 | Moxifloxacin | FAERS: 1 | US FAERS | |
| 45 | Nitrofurantoin | FAERS: 1 | US FAERS | |
| 46 | Olanzapine | FAERS: 1 | SIDER US FAERS | |
| 47 | Paroxetine | FAERS: 1 | SIDER US FAERS | |
| 48 | Pentobarbital | FAERS: 1 | US FAERS | |
| 49 | Promethazine | FAERS: 1 | US FAERS | |
| 50 | Thyroxine | FAERS: 1 | US FAERS | |
| 51 | Valproic Acid | FAERS: 1 | US FAERS | |
| 52 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 53 | fosphenytoin | FAERS: 1 | US FAERS | |
| 54 | rotigotine | FAERS: 1 | US FAERS | |
| 55 | sofosbuvir-velpatasvir drug combination | FAERS: 1 | US FAERS | |
| 56 | ziprasidone | FAERS: 1 | SIDER US FAERS | |
| 57 | Amphetamine | SIDER | ||
| 58 | Astemizole | Canada Vigilance: 1 | Canada Vigilance | |
| 59 | Citalopram | SIDER | ||
| 60 | Clomipramine | SIDER | ||
| 61 | Felbamate | SIDER | ||
| 62 | Fluoxetine | Canada Vigilance: 1 | Canada Vigilance | |
| 63 | Fluphenazine | SIDER | ||
| 64 | Gabapentin | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 65 | Loxapine | SIDER | ||
| 66 | Paliperidone Palmitate | SIDER | ||
| 67 | Pergolide | SIDER | ||
| 68 | Prochlorperazine | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Quetiapine Fumarate | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 70 | Sumatriptan | SIDER | ||
| 71 | Thioridazine | SIDER | ||
| 72 | Tiagabine | SIDER | ||
| 73 | Tolcapone | SIDER | ||
| 74 | carbidopa, levodopa drug combination | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | carbromal | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | ropinirole | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.